Similar articles

• [Editorial: Hebebrand, J., Blanz, B., Herpertz-Dahlmann, B. & Lehmkuhl, G. 2012. Increase in the abundance of medical treatments, ethical principles and conflicts of interest in cooperation with the pharmaceutical industry].

  Frank R. Frank R. Z Kinder Jugendpsychiatr Psychother. 2013 Mar;41(2):145-9. doi: 10.1024/1422-4917/a000221. Z Kinder Jugendpsychiatr Psychother. 2013. PMID: 23425616 German. No abstract available.
• Financial ties between authors of the clinical practice guidelines and pharmaceutical companies: an example from Japan.

  Saito H, Tani Y, Ozaki A, Sawano T, Shimada Y, Yamamoto K, Tanimoto T. Saito H, et al. Clin Microbiol Infect. 2019 Nov;25(11):1304-1306. doi: 10.1016/j.cmi.2019.07.025. Epub 2019 Aug 8. Clin Microbiol Infect. 2019. PMID: 31401175 No abstract available.
• Vaccines: for whose benefit?

  Paul Y. Paul Y. Indian J Med Ethics. 2010 Jan-Mar;7(1):30-1. doi: 10.20529/IJME.2010.011. Indian J Med Ethics. 2010. PMID: 20166295 No abstract available.
• Physician's prescription and pharmaceutical industry's influence - where have the ethics gone?

  Ahmer Z. Ahmer Z. J Pak Med Assoc. 2024 Nov;74(11 (Supple-12)):S44-S46. doi: 10.47391/JPMA.AKU-EPP-09. J Pak Med Assoc. 2024. PMID: 39648175 Review.
• [Conflict of interest regarding clinical physicians' relationship with pharmaceutical industry and medical education].

  Miyata Y. Miyata Y. Seishin Shinkeigaku Zasshi. 2010;112(11):1136-45. Seishin Shinkeigaku Zasshi. 2010. PMID: 21226250 Review. Japanese.